APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurorehabilitation

Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.

What turns activity into demand

Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.

The commercial boundary

For Neurorehabilitation, distinguish the supplied service or configured system from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable neurorehabilitation performance?

Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.

Selected research

Market Outlook & Growth Opportunities

Global Neurorehabilitation Market Outlook and Growth Opportunities 2026

1 January 2026193 pages

Choose your research edition.

Industry ResearchNeurorehabilitation Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurorehabilitation Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Neurorehabilitation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurorehabilitation Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurorehabilitation Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Neurorehabilitation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Neurorehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neurorehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurorehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Neurorehabilitation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Neurorehabilitation market include VISHEE, Beijing Bo'ai Hospital, Beijing Rehabilitation Hospital of Capital Medical University, NCC, CHIEFTAIN, Tongji Hospital, Haobro Medical Device, DIH and Sun Java, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Neurorehabilitation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurorehabilitation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurorehabilitation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Neurorehabilitation market.

Neurorehabilitation Segment by Company

VISHEE

Beijing Bo'ai Hospital

Beijing Rehabilitation Hospital of Capital Medical University

NCC

CHIEFTAIN

Tongji Hospital

Haobro Medical Device

DIH

Sun Java

Aoyang Health

PKUCare Rehabilitation Hospital

Beijing Puhua International Hospital

Xiangyu Medical

Beijing United Family Rehabilitation Hospital

Neurorehabilitation Segment by Type

Brain Injury

Spinal Cord Injury

Peripheral Nerve Injury

Other

Neurorehabilitation Segment by Application

General Hospital

Rehabilitation Specialist Hospital

Community Rehabilitation Center

Neurorehabilitation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neurorehabilitation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Neurorehabilitation key companies, revenue, market share, and recent developments.

3. To split the Neurorehabilitation breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Neurorehabilitation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neurorehabilitation significant trends, drivers, influence factors in global and regions.

6. To analyze Neurorehabilitation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurorehabilitation industry.

Chapter 3: Detailed analysis of Neurorehabilitation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Neurorehabilitation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Neurorehabilitation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neurorehabilitation Industry Trends Table 2. Neurorehabilitation Industry Drivers Table 3. Neurorehabilitation Industry Opportunities and Challenges Table 4. Neurorehabilitation Industry Restraints Table 5. Global Neurorehabilitation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neurorehabilitation Revenue Share by Company (2021-2026) Table 7. Global Neurorehabilitation Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Neurorehabilitation Key Company Manufacturing Base & Headquarters Table 9. Global Neurorehabilitation Company, Product Type & Application Table 10. Global Neurorehabilitation Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Neurorehabilitation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Brain Injury Table 15. Significant Companies of Spinal Cord Injury Table 16. Significant Companies of Peripheral Nerve Injury Table 17. Significant Companies of Other Table 18. Global Neurorehabilitation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Neurorehabilitation Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Neurorehabilitation Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Neurorehabilitation Sales Value Share by Type (2021-2026) Table 22. Global Neurorehabilitation Sales Value Share by Type (2027-2032) Table 23. Significant Companies of General Hospital Table 24. Significant Companies of Rehabilitation Specialist Hospital Table 25. Significant Companies of Community Rehabilitation Center Table 26. Global Neurorehabilitation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Neurorehabilitation Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Neurorehabilitation Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Neurorehabilitation Sales Value Share by Application (2021-2026) Table 30. Global Neurorehabilitation Sales Value Share by Application (2027-2032) Table 31. Global Neurorehabilitation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Neurorehabilitation Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Neurorehabilitation Sales Value Share by Region (2021-2026) Table 34. Global Neurorehabilitation Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Neurorehabilitation Sales Value Share by Region (2027-2032) Table 36. Global Neurorehabilitation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Neurorehabilitation Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Neurorehabilitation Sales Value Market Share by Country (2021-2026) Table 39. Global Neurorehabilitation Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Neurorehabilitation Sales Value Market Share by Country (2027-2032) Table 41. VISHEE Company Information Table 42. VISHEE Business Overview Table 43. VISHEE Neurorehabilitation Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. VISHEE Neurorehabilitation Product Portfolio Table 45. VISHEE Recent Development Table 46. Beijing Bo'ai Hospital Company Information Table 47. Beijing Bo'ai Hospital Business Overview Table 48. Beijing Bo'ai Hospital Neurorehabilitation Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Beijing Bo'ai Hospital Neurorehabilitation Product Portfolio Table 50. Beijing Bo'ai Hospital Recent Development Table 51. Beijing Rehabilitation Hospital of Capital Medical University Company Information Table 52. Beijing Rehabilitation Hospital of Capital Medical University Business Overview Table 53. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Product Portfolio Table 55. Beijing Rehabilitation Hospital of Capital Medical University Recent Development Table 56. NCC Company Information Table 57. NCC Business Overview Table 58. NCC Neurorehabilitation Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. NCC Neurorehabilitation Product Portfolio Table 60. NCC Recent Development Table 61. CHIEFTAIN Company Information Table 62. CHIEFTAIN Business Overview Table 63. CHIEFTAIN Neurorehabilitation Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. CHIEFTAIN Neurorehabilitation Product Portfolio Table 65. CHIEFTAIN Recent Development Table 66. Tongji Hospital Company Information Table 67. Tongji Hospital Business Overview Table 68. Tongji Hospital Neurorehabilitation Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Tongji Hospital Neurorehabilitation Product Portfolio Table 70. Tongji Hospital Recent Development Table 71. Haobro Medical Device Company Information Table 72. Haobro Medical Device Business Overview Table 73. Haobro Medical Device Neurorehabilitation Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Haobro Medical Device Neurorehabilitation Product Portfolio Table 75. Haobro Medical Device Recent Development Table 76. DIH Company Information Table 77. DIH Business Overview Table 78. DIH Neurorehabilitation Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. DIH Neurorehabilitation Product Portfolio Table 80. DIH Recent Development Table 81. Sun Java Company Information Table 82. Sun Java Business Overview Table 83. Sun Java Neurorehabilitation Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sun Java Neurorehabilitation Product Portfolio Table 85. Sun Java Recent Development Table 86. Aoyang Health Company Information Table 87. Aoyang Health Business Overview Table 88. Aoyang Health Neurorehabilitation Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Aoyang Health Neurorehabilitation Product Portfolio Table 90. Aoyang Health Recent Development Table 91. PKUCare Rehabilitation Hospital Company Information Table 92. PKUCare Rehabilitation Hospital Business Overview Table 93. PKUCare Rehabilitation Hospital Neurorehabilitation Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 94. PKUCare Rehabilitation Hospital Neurorehabilitation Product Portfolio Table 95. PKUCare Rehabilitation Hospital Recent Development Table 96. Beijing Puhua International Hospital Company Information Table 97. Beijing Puhua International Hospital Business Overview Table 98. Beijing Puhua International Hospital Neurorehabilitation Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 99. Beijing Puhua International Hospital Neurorehabilitation Product Portfolio Table 100. Beijing Puhua International Hospital Recent Development Table 101. Xiangyu Medical Company Information Table 102. Xiangyu Medical Business Overview Table 103. Xiangyu Medical Neurorehabilitation Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 104. Xiangyu Medical Neurorehabilitation Product Portfolio Table 105. Xiangyu Medical Recent Development Table 106. Beijing United Family Rehabilitation Hospital Company Information Table 107. Beijing United Family Rehabilitation Hospital Business Overview Table 108. Beijing United Family Rehabilitation Hospital Neurorehabilitation Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 109. Beijing United Family Rehabilitation Hospital Neurorehabilitation Product Portfolio Table 110. Beijing United Family Rehabilitation Hospital Recent Development Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Neurorehabilitation Product Image Figure 2. Global Neurorehabilitation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurorehabilitation Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurorehabilitation Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Brain Injury Image Figure 8. Spinal Cord Injury Image Figure 9. Peripheral Nerve Injury Image Figure 10. Other Image Figure 11. Global Neurorehabilitation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Neurorehabilitation Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Neurorehabilitation Sales Value Share by Type (2021-2032) Figure 14. General Hospital Image Figure 15. Rehabilitation Specialist Hospital Image Figure 16. Community Rehabilitation Center Image Figure 17. Global Neurorehabilitation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Neurorehabilitation Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Neurorehabilitation Sales Value Share by Application (2021-2032) Figure 20. Global Neurorehabilitation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Neurorehabilitation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Neurorehabilitation Sales Value (2021-2032) & (US$ Million) Figure 23. North America Neurorehabilitation Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Neurorehabilitation Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Neurorehabilitation Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Neurorehabilitation Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Neurorehabilitation Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Neurorehabilitation Sales Value (2021-2032) & (US$ Million) Figure 29. South America Neurorehabilitation Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Neurorehabilitation Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Neurorehabilitation Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Neurorehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Neurorehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Neurorehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Brain Injury
  • Spinal Cord Injury
  • Peripheral Nerve Injury
  • Other
Applications
  • General Hospital
  • Rehabilitation Specialist Hospital
  • Community Rehabilitation Center
Companies covered
  • VISHEE
  • Beijing Bo'ai Hospital
  • Beijing Rehabilitation Hospital of Capital Medical University
  • NCC
  • CHIEFTAIN
  • Tongji Hospital
  • Haobro Medical Device
  • DIH
  • Sun Java
  • Aoyang Health
  • PKUCare Rehabilitation Hospital
  • Beijing Puhua International Hospital
  • Xiangyu Medical
  • Beijing United Family Rehabilitation Hospital

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neurorehabilitation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neurorehabilitation Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Neurorehabilitation Market Dynamics
  1. 2.1 Neurorehabilitation Industry Trends
  2. 2.2 Neurorehabilitation Industry Drivers
  3. 2.3 Neurorehabilitation Industry Opportunities and Challenges
  4. 2.4 Neurorehabilitation Industry Restraints
3 Neurorehabilitation Market by Company
  1. 3.1 Global Neurorehabilitation Company Revenue Ranking in 2025
  2. 3.2 Global Neurorehabilitation Revenue by Company (2021-2026)
  3. 3.3 Global Neurorehabilitation Company Ranking (2024-2026)
  4. 3.4 Global Neurorehabilitation Company Manufacturing Base and Headquarters
  5. 3.5 Global Neurorehabilitation Company Product Type and Application
  6. 3.6 Global Neurorehabilitation Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Neurorehabilitation Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Neurorehabilitation Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Neurorehabilitation Market by Type
  1. 4.1 Neurorehabilitation Type Introduction
  2. 4.1.1 Brain Injury
  3. 4.1.2 Spinal Cord Injury
  4. 4.1.3 Peripheral Nerve Injury
  5. 4.1.4 Other
  6. 4.2 Global Neurorehabilitation Sales Value by Type
  7. 4.2.1 Global Neurorehabilitation Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Neurorehabilitation Sales Value by Type (2021-2032)
  9. 4.2.3 Global Neurorehabilitation Sales Value Share by Type (2021-2032)
5 Neurorehabilitation Market by Application
  1. 5.1 Neurorehabilitation Application Introduction
  2. 5.1.1 General Hospital
  3. 5.1.2 Rehabilitation Specialist Hospital
  4. 5.1.3 Community Rehabilitation Center
  5. 5.2 Global Neurorehabilitation Sales Value by Application
  6. 5.2.1 Global Neurorehabilitation Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurorehabilitation Sales Value by Application (2021-2032)
  8. 5.2.3 Global Neurorehabilitation Sales Value Share by Application (2021-2032)
6 Neurorehabilitation Regional Value Analysis
  1. 6.1 Global Neurorehabilitation Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurorehabilitation Sales Value by Region (2021-2032)
  3. 6.2.1 Global Neurorehabilitation Sales Value by Region: 2021-2026
  4. 6.2.2 Global Neurorehabilitation Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neurorehabilitation Sales Value (2021-2032)
  7. 6.3.2 North America Neurorehabilitation Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Neurorehabilitation Sales Value (2021-2032)
  10. 6.4.2 Europe Neurorehabilitation Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Neurorehabilitation Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Neurorehabilitation Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Neurorehabilitation Sales Value (2021-2032)
  16. 6.6.2 South America Neurorehabilitation Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Neurorehabilitation Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Neurorehabilitation Sales Value Share by Country, 2025 VS 2032
7 Neurorehabilitation Country-level Value Analysis
  1. 7.1 Global Neurorehabilitation Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neurorehabilitation Sales Value by Country (2021-2032)
  3. 7.2.1 Global Neurorehabilitation Sales Value by Country (2021-2026)
  4. 7.2.2 Global Neurorehabilitation Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Neurorehabilitation Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Neurorehabilitation Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Neurorehabilitation Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Neurorehabilitation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Neurorehabilitation Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Neurorehabilitation Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Neurorehabilitation Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Neurorehabilitation Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Neurorehabilitation Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Neurorehabilitation Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Neurorehabilitation Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Neurorehabilitation Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Neurorehabilitation Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Neurorehabilitation Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Neurorehabilitation Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Neurorehabilitation Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Neurorehabilitation Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Neurorehabilitation Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Neurorehabilitation Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Neurorehabilitation Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Neurorehabilitation Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Neurorehabilitation Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Neurorehabilitation Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Neurorehabilitation Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Neurorehabilitation Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Neurorehabilitation Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Neurorehabilitation Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Neurorehabilitation Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Neurorehabilitation Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Neurorehabilitation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 VISHEE
  2. 8.1.1 VISHEE Company Information
  3. 8.1.2 VISHEE Business Overview
  4. 8.1.3 VISHEE Neurorehabilitation Revenue and Gross Margin (2021-2026)
  5. 8.1.4 VISHEE Neurorehabilitation Product Portfolio
  6. 8.1.5 VISHEE Recent Developments
  7. 8.2 Beijing Bo'ai Hospital
  8. 8.2.1 Beijing Bo'ai Hospital Company Information
  9. 8.2.2 Beijing Bo'ai Hospital Business Overview
  10. 8.2.3 Beijing Bo'ai Hospital Neurorehabilitation Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Bo'ai Hospital Neurorehabilitation Product Portfolio
  12. 8.2.5 Beijing Bo'ai Hospital Recent Developments
  13. 8.3 Beijing Rehabilitation Hospital of Capital Medical University
  14. 8.3.1 Beijing Rehabilitation Hospital of Capital Medical University Company Information
  15. 8.3.2 Beijing Rehabilitation Hospital of Capital Medical University Business Overview
  16. 8.3.3 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Product Portfolio
  18. 8.3.5 Beijing Rehabilitation Hospital of Capital Medical University Recent Developments
  19. 8.4 NCC
  20. 8.4.1 NCC Company Information
  21. 8.4.2 NCC Business Overview
  22. 8.4.3 NCC Neurorehabilitation Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NCC Neurorehabilitation Product Portfolio
  24. 8.4.5 NCC Recent Developments
  25. 8.5 CHIEFTAIN
  26. 8.5.1 CHIEFTAIN Company Information
  27. 8.5.2 CHIEFTAIN Business Overview
  28. 8.5.3 CHIEFTAIN Neurorehabilitation Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CHIEFTAIN Neurorehabilitation Product Portfolio
  30. 8.5.5 CHIEFTAIN Recent Developments
  31. 8.6 Tongji Hospital
  32. 8.6.1 Tongji Hospital Company Information
  33. 8.6.2 Tongji Hospital Business Overview
  34. 8.6.3 Tongji Hospital Neurorehabilitation Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tongji Hospital Neurorehabilitation Product Portfolio
  36. 8.6.5 Tongji Hospital Recent Developments
  37. 8.7 Haobro Medical Device
  38. 8.7.1 Haobro Medical Device Company Information
  39. 8.7.2 Haobro Medical Device Business Overview
  40. 8.7.3 Haobro Medical Device Neurorehabilitation Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Haobro Medical Device Neurorehabilitation Product Portfolio
  42. 8.7.5 Haobro Medical Device Recent Developments
  43. 8.8 DIH
  44. 8.8.1 DIH Company Information
  45. 8.8.2 DIH Business Overview
  46. 8.8.3 DIH Neurorehabilitation Revenue and Gross Margin (2021-2026)
  47. 8.8.4 DIH Neurorehabilitation Product Portfolio
  48. 8.8.5 DIH Recent Developments
  49. 8.9 Sun Java
  50. 8.9.1 Sun Java Company Information
  51. 8.9.2 Sun Java Business Overview
  52. 8.9.3 Sun Java Neurorehabilitation Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sun Java Neurorehabilitation Product Portfolio
  54. 8.9.5 Sun Java Recent Developments
  55. 8.10 Aoyang Health
  56. 8.10.1 Aoyang Health Company Information
  57. 8.10.2 Aoyang Health Business Overview
  58. 8.10.3 Aoyang Health Neurorehabilitation Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aoyang Health Neurorehabilitation Product Portfolio
  60. 8.10.5 Aoyang Health Recent Developments
  61. 8.11 PKUCare Rehabilitation Hospital
  62. 8.11.1 PKUCare Rehabilitation Hospital Company Information
  63. 8.11.2 PKUCare Rehabilitation Hospital Business Overview
  64. 8.11.3 PKUCare Rehabilitation Hospital Neurorehabilitation Revenue and Gross Margin (2021-2026)
  65. 8.11.4 PKUCare Rehabilitation Hospital Neurorehabilitation Product Portfolio
  66. 8.11.5 PKUCare Rehabilitation Hospital Recent Developments
  67. 8.12 Beijing Puhua International Hospital
  68. 8.12.1 Beijing Puhua International Hospital Company Information
  69. 8.12.2 Beijing Puhua International Hospital Business Overview
  70. 8.12.3 Beijing Puhua International Hospital Neurorehabilitation Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Beijing Puhua International Hospital Neurorehabilitation Product Portfolio
  72. 8.12.5 Beijing Puhua International Hospital Recent Developments
  73. 8.13 Xiangyu Medical
  74. 8.13.1 Xiangyu Medical Company Information
  75. 8.13.2 Xiangyu Medical Business Overview
  76. 8.13.3 Xiangyu Medical Neurorehabilitation Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Xiangyu Medical Neurorehabilitation Product Portfolio
  78. 8.13.5 Xiangyu Medical Recent Developments
  79. 8.14 Beijing United Family Rehabilitation Hospital
  80. 8.14.1 Beijing United Family Rehabilitation Hospital Company Information
  81. 8.14.2 Beijing United Family Rehabilitation Hospital Business Overview
  82. 8.14.3 Beijing United Family Rehabilitation Hospital Neurorehabilitation Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Beijing United Family Rehabilitation Hospital Neurorehabilitation Product Portfolio
  84. 8.14.5 Beijing United Family Rehabilitation Hospital Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst